Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

NCT03743649 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Delirium
Locally Advanced Malignant Neoplasm
Metastatic Malignant Neoplasm
Recurrent Malignant Neoplasm

Interventions

DRUG: Haloperidol
DRUG: Lorazepam
OTHER: Placebo
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]